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INTRODUCTION 
Blood stream infections (BSI) are the major cause of morbidity & 
mortality among patients admitted in Intensive care unit & surveillance of 
etiological agents in these infections are important for their prevention & 
treatment. Blood stream infection is the infection that required one or more 
cultures positive for a bacteria or a fungus of blood samples obtained in the 
presence of fever(>380C) not attributable to other causes(based on US 
centers of Disease control & prevention1). 
Community acquired Bacteremia (CAP) was defined if the first 
positive blood culture was obtained before or within 48 hours of 
hospitalization.  Blood stream infections are considered to be nosocomial if 
signs & symptoms of these infections became evident after 48 hours 
following hospital admission and/or if the patient had been hospitalized 
during the 2 weeks before the current admission. 
The invasion of microorganisms in the circulating blood pose amajor 
threat  to every organ  in the body leading to serious consequences including 
shock, multiple Organ failure, DIC & Death. Blood stream infections with 
primary diseases admitted in ICU are Infective Endocarditis, 
CAP(community acquired pneumonia), Uro-sepsis & Meningitis2. BSI  with 
Secondary Bacteremia are infections resulting from health care 
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interventions such as Vascular catheter insertion, infection following 
Urinary catheter related sepsis, infection of Surgical sites & infection arising 
out of hospital acquiredor ventilator associated pneumonia.Vascular access 
devices are inserted in critically ill patients for the maintenance of fluid 
Electrolyte Balance, administration of Drugs, maintaining nutritional 
requirements, monitoring vital parameters, promoting vital organ support & 
doing essential investigation3. 
The only way to avoid infections from this intervention is strict 
attention to asepsis during insertion of vascular access devices, regular 
review of each vascular channel so that they are kept as long as essential. 
The use of Chlorhexidine-based preparations & insertion of Central line 
through the Subclavian access reduce infection rate4,5 .The patients with BSI 
manifest clinically with systemic signs of infection such as Fever, 
Leucocytosis, raised inflammatory markers. Blood cultures obtained from 
both peripheral &vascular access device are to be taken within 15 minute6 
detects CR-BSI .So the patients in ICU with sepsis are empirically treated 
with Glycopeptide antibiotics like Vancomycin to cover Gram positive 
pathogens(Methicillin sensitive and methicillin resistant Staphylococcus 
aureus and S.epidermidis). In many cases of CRBSI removal of vascular 
access device is the mainstay of treatment to prevent further complication2,3. 
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According to one American study, the incidence of Bacteremia in 
critical care settings was estimated to be 3 cases per 1000 population7with 
Mortality rate between 20 % to 50 % & Mean mortality rate of 28.6%. 
Similar study showed Mortality rate of 34% at 28 days & 45% at 5 months. 
Patients who developed Sepsis after the 2nd day in the hospital had even 
higher mortality than those who were septic on admission5. 
The most common bacteria isolated from   patients in ICU are gram 
positive aerobic bacteria (S.aureus, Enterococcus) and gram negative 
aerobic bacteria (Enterobacteriaceae, Pseudomonas aeruginosa) & the 
common fungi include Candida albicans in both immune competent & 
immune compromised patients2. CONS which was previously considered as 
contaminants have increased in clinical importance & are now recognized as 
pathogens4,9. They are the etiologic agents of catheter associated bacteremia 
in patients with Vascular & other prosthesis.So judging its clinical 
significance is very challenging. 
Blood cultures arethe most important laboratory test performed in the 
diagnosis of serious infection and leads to a definitive diagnosis against the 
causative organisms.So the Blood culture is considered as the gold standard 
for the detection of bacteremia4. This study was taken in our institution to 
evaluate the prevalence of Septicaemia in ICU patients in our setup in 
relation to their source of infection. It is done to ascertain the importance of 
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Blood culture examination for the detection of BSI in ICU patients that 
helps in treating and decreasing is the morbidity & mortality due to 
Community acquired & Nosocomial Blood stream infections.There is 
considerable increase in incidence of vascular infection caused by bacteria 
that are normally considered avirulent. So it is important to distinguish 
between contaminants & pathogen.13 
 
TO BE A PROBABLE CONTAMINANT2: 
 Growth of CONS, bacillus spp., Corynebacterium spp., in only one of 
several cultures. 
 Growth of multiple organisms from only one of several cultures.  
 The clinical signs are not consistent with sepsis. 
 The organism causing the infection at the primary site & the organism 
isolated from the blood culture are different. 
 
TO BE A PROBABLE PATHOGEN2,7: 
 Growth of same organisms in repeated cultures obtained either at 
different times or from different anatomical sites. 
 Growth of organisms from suspected case of Endocarditis. 
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 Growth of organisms from members of Enterobacteriaceae, S 
pneumonia, Gram negative anaerobes & S Pyogenes. 
 Isolation of commensal bacteria from Blood culture of patients 
suspected to be Bacteremic (Immunocompromised patients or those 
valves). 
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AIMS & OBJECTIVES 
 
1. To isolate the pathogen causing infection in intensive care unit. 
2. To identify the possible source of infection. 
3. To determine the antimicrobial susceptibility pattern of the 
isolates. 
4. To study the resistance pattern of the common isolates. 
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REVIEW OF LITERATURE 
HISTORY 
The term Sepsis was derived from a Greek word meaning 
“PUTRID3”. It was believed that putrefaction of wound was caused by 
contact with air & leading to death when theprocess of putrefaction reached 
the blood (Septicaemia). In the 19th century, the concept of infection as a 
cause of sepsis was introduced by Austrian obstetrician, Ignaz Philip 
Semmelweis & the English surgeon Joseph Lister.Since then the term Sepsis 
was closely related to Bacterial infection. 
DEFINITION  
The most widely used set of definitions was developed by consensus 
committee of experts in 199215,16. The American College of chest physicians 
/ society of critical care medicine (ACCP/ SCCM) consensus conference 
defined Sepsis as a systemic inflammatory response syndrome (SIRS) 
caused by infectious process2. 
SIRS (SYSTEMIC INFLAMMATORY RESPONSE SYNDROME)15: 
SIRS is an abnormal generalized inflammatory reaction in organs 
remote from the initial insult. SIRS is defined as the systemic response to a 
wide range of stresses. Currently used Criteria include >2 of the following. 
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SIRS CRITERIA3,7,15,16: 
 Temperature > 38ºC or < 36ºC 
 Heart Rate > 90 beats / minute  
 Respiratory rate > 20 breaths / min  
 WBC > 12000 Cells / mm3 or < 4000 Cells / mm3 or > 10% immature 
neutrophils (band) forms.  
SEPSIS : 
Sepsis is defined as an invasion of microorganisms or their toxins into 
the blood stream together with the host response to this invasion. 
If SIRS occurs in a patient with proven or suspected infection, it is 
known as sepsis. SIRS is called sepsis in the American consensus scheme16. 
BACTEREMIA: 
Presence of bacteria in blood, as evidenced by positive blood cultures. 
SEPTICAEMIA: 
Presence of microbes or their toxins in blood. Septicaemia is a 
clinical syndrome characterized by fever, chills, malaise, tachycardia, 
hyperventilation and toxicity (or) prostration19. 
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SEVERE SEPSIS : 
Sepsis with one or more signs of organ dysfunction of the 
following.16,17 
1. CVS – SBP < 90 mm Hg 
2. Renal – Urine output < 0.5ml/kg/hr for 1 hr 
3. Respiratory – PO2 / FIO2 < 250 
4. Hematologic – platelet count < 80,000/ml or 50% decrease in platelet 
count recorded for past 3 days  
SEPTIC SHOCK15:  
Sepsis with hypotension (SBP<90 mmHg, for at least one hour 
despite adequate fluid resuscitation. 
RETRACTORY SEPTIC SHOCK15,17: 
Septic shock that lasts for > 1 hour & does not respond to fluid or 
vasopressor administration. 
MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)15: 
Dysfunction of more than one organ, requiring intervention to 
maintain homeostasis. 
Another American conference in 2001, reconsidered definitions for 
Sepsis and proposed a new system for staging sepsis based on 
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predisposition insult,infection response and organ dysfunction (known 
as PIRO)3. For simplicity and convenience, the 1992 definitions are used 
widely. 
EPIDEMIOLOGY : 
Sepsis account for more than 2,00,000 deaths per year in US. Sepsis 
related incidence and mortality rates increases with age and preexisting co 
morbidity. In a survey of hospital discharge records from Seven States in 
1995, Angus and Colleagues18  estimated the annual incidence of sepsis to 
be 300 cases per 1,00,000 population. The estimated crude mortality rate 
was 28%. The median age for patients with sepsis is approximately 60 
years. The attack rate in very high in infants. 
A survey conducted in the Intensive Care Units in the US3 and 
Europe during the year 1990 and 2000 approximately 70 to 80% of cases of 
severe Sepsis in adults occurred in individuals who were already 
hospitalized for other reasons. In 30 to 50% cases no definite etiology was 
found.  
Sepsis caused by gram positive bacteria has steadily increased over 
the last two decades. Staphylococcus aureus, CONS and Enterococci 
account for approximately 30 to 50% of cases in most clinical setting. 
Another recent trend is the emergence of fungi particularly candida as 
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etiological agents in blood stream infections. Candida spp. caused 5 to 20% 
of sepsis cases2.  
PATHOPHYSIOLOGY OF SEPSIS: 
Infection is initiated when bacteria penetrate host barriers like skin 
and mucosa. Depending on the virulence of infecting agents, immune status 
of the patients, local host defense mechanism is overwhelmed, leading to 
microbial invasion of the bloodstream. Sepsis is characterized by loss of 
hemostatic balance and endothelial dysfunction, which in turn severely 
compromise the cardio circulatory system as well as intracellular 
hemostasis. Cellular hypoxia and apoptosis then contribute to organ 
dysfunction and death. 
 
PATHOPHYSIOLOGY OF SEPSIS IN SCHEMATIC ORDER7,20 : 
 Microbial stimulus  
 Host immune response in sepsis  
 Loss of hemostatic balance  
 Endothelial dysfunction  
 Cardiac and circulatory dysfunction (microcirculatory dysfunction)     
 Endocrine dysfunction  
 Tissue hypoxia  
 Apoptosis  
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MICROBIOLOGICAL STIMULUS  
Gram Negative Sepsis: 
In gram negative bacteremia, initiation of the immune response is 
mediated by LPS (Lipopolysaccharide), a bacterial cell wall product. In 
plasma, LPS is bound to LPS binding protein (LBP). Bound LPS is 
transported to opsonic receptor CD14, which is located on several cell 
membranes including on monocytes18. A soluble form of CD14 interacts 
with CD14 negative cells. (eg Dendritic cells). However, CD14 alone 
cannot explain the action of LPS, because CD14 does not have an 
intercellular tail. 
Another binding site of LPS in transmembrane receptor TLR 4 (Toll 
Like Receptor), which exist in combination with the accessory protein 
MD215.The binding of LPS to CD14 and TLR 4, induces via other 
molecules activation of the transcription factor, nuclear factor kappa B   
(NF-kB). Activated kB migrates into the nucleus where it binds to and 
activates gene promoters, resulting in the transcription and expression of 
genes for cytokines and other proinflammatory mediators17. In monocytes 
LPS also induces cytokine transcription via the triggering receptors 
expressed on myeloid cells-1 and the myeloid DAP-12 associated lectin14. 
Intracellular pattern recognition protein in monocytes for LPS has recently 
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been identified as another pathway of cytokine expression and include 
nucleotide binding oligomerization domain 1 & 2 as LPS binding sites20.  
Gram Positive Sepsis  
During the last decade, gram positive bacteria have gained greater 
importance as causative organisms for sepsis19. They lack endotoxin and are 
recognized by cell wall components such as peptidoglycans and released 
bacterial toxins (exotoxins). Recently, LTA (Lipotechoic acid), a component 
of the cell wall in all gram positive bacteria, has been recognized as main 
pattern for recognition of gram positive bacteria. TLR2 has been identified 
as the only pattern recognition protein for gram positive bacteria18. TLR 2 is 
not a specific receptor for LTA. Clinically gram positive sepsis and gram 
negative sepsis are not distinguished. Peptidoglycans and LTA stimulate the 
release of TNF α, IL 6 & IL 10.  
BLOODSTREAM INFECTIONS: 
Microorganisms enter the blood stream by various mechanisms and 
lead to complications like shock, multiple organ failure, disseminated 
intravascular coagulation (DIC) and death. The microbial agents causing 
bacteremia are bacteria, fungi, viruses and parasites2. 
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TYPES OF BLOOD STREAM INFECTIONS : 
Bacteremia can be transient, intermittent or continuous  
1. TRANSIENT BACTEREMIA :  This occurs when organisms (alters 
members of normal flora) are introduced into the blood stream, by 
minimal trauma to membranes (eg brushing of teeth, straining during 
bowel movements, medical procedures21). 
2. INTERMITTENT BACTEREMIA: This occurs when bacteria from 
any infected site are periodically released into the blood. (eg. Abscess, 
colitis, infection of body cavities) 
3. CONTINUOUS BACTEREMIA: This occurs when infection is 
intravascular like infected endothelial surface (endocarditis or 
aneurysms), infected devices (AV fistulas, indwelling cannulas, intra 
arterial catheters19) 
Bacteremia can be primary or secondary 
1. PRIMARY BSI: BSI is called primary if the point of entry of 
infection or focus cannot be determined or if it arises from an 
intravascular catheter [catheter related BSI (CRBSI)]. 
2. SECONDARY BSI:  BSI is called secondary if any distant site other 
than an Intravenous catheter is established as the portal of entry or 
origin. 
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Bacteremia can be community acquired or nosocomial depending on 
epidemiological settings20. 
1. COMMUNITY ACQUIRED BACTEREMIA: It is detected within 
48 hours of admission and the patients should not be hospitalized 
within previous 30 days and there should not be any recent history of 
invasive procedures (eg Foley catheter, IV catheter, Central venous 
catheter or dialysis) 
2. NOSOCOMIAL ACQUIRED BACTEREMIA: It is detected after 
48 hours of admission in hospital and is associated with long term 
hospital stay, invasive procedures, long term antibiotic therapy. 
The major classification of blood stream infection are 
1. INTRAVASCULAR INFECTION: Infection that originates within 
cardiovascular system contributes to intravascular infection. It 
includes infective endocarditis, Mycotic aneurysm, Catheter related 
bacteremia and Suppurative thrombophlebitis. These infections are 
life threatening and leads to serious illness. 
2. EXTRAVASCULARINFECTION : Here the bacteria invades the 
circulation through the lymphatic system. Most cases of clinically 
significant BSI are due to extravascular infection. 
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The most common routes of extravascular infection are genitourinary 
tract (25%), respiratory tract (20%), abscesses (10%), surgical wound 
infection (5%), biliary tract (5%) and other unknown sites(25%) .In one 
third of  bacteremia source  of infection is not identified. Organisms causing 
BSI through extravascular sites are members of the family 
Enterobacteriaceae, Streptococcus pneumonia, Staphylococcusaureus, 
anaerobic cocci, Neisseria gonorrhoeae, Clostridium spp, Bacteroides, Beta 
hemolytic Streptococci and Pseudomonas.2 
RISK FACTORS: 
The risk factors & underlying conditions of BSI are 
immunosuppression, irrational use of antibiotics that leads to emergence of 
resistance to drugs, invasive procedures that allow microorganisms to enter 
the host, surgical procedures, underlying organ failure and Malignancy15. 
CLINICAL FEATURES: 
The clinical features or presentation ranges from mild symptoms 
occurring from transient bacteremia to fulminant sepsis leading to Septic 
shock, DIC, high mortality and lifethreatening complications.Continuous 
bacteremia is associated with endocarditis (intravascular) or other 
extravascular infection like typhoid fever (for first week) or brucellosis. 
Transient bacteremia occurs following any minor surgeries or manipulation. 
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Intermittent bacteremia is commonly secondary to any local abscess. 
Fever is the most common presenting symptoms in almost all patients with 
intermittent and continuous bacteremia. Other clinical features include 
increased respiratory rate, heart rate and decreased blood pressure. Bryan 
emphasized that patients with positive blood cultures are 12 times more 
likely to die during hospitalization than patients with negative blood 
cultures23. 
MICROBIAL PATHOGENS IN BSI: 
In recent studies done by Pittet et al, Valles et al 2009, about 50-60% 
were caused by gram negative organisms and 20-30% by gram positive 
organisms. Fungi mainly candida contribute to 6-10% of episodes. The  
most common organisms in BSI are Coagulase negative staphylococci, 
Staphylococcus aureus, Enterococci, Candida spp, E.coli, Klebsiellaspp, 
P.aeruginosa, Enterobacterspp, Acinetobacter spp27. 
STAPHYLOCOCCUS AUREUS: 
Staphylococcus aureus is a part of normal humanflora. The anterior 
nares is the common site of human colonization but it can also be seen in the 
skin (when damaged), vagina, axilla, perineum and Oropharynx. 25-50% of 
healthy persons are usually colonized with Staphylococcus aureus. The 
colonization rate is higher in immunosuppressed conditions. It is the leading 
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cause of nosocomial infection. Staphylococcus aureus is the most common 
cause of surgical wound infections. It is the second most common cause of   
primary bacteremia next to CONS15. Nosocomial organism is multi drug 
resistant. Methicillin resistance now commonly called as MRSA was first 
reported by Barber in 1961. From then MRSA was a major clinical and 
epidemiological problem in hospitals and critical care settings. MRSA BSI 
is most commonly seen in ICU setup and Hospital acquired infections. 
Although among the community acquired infections S.aureus is an 
important cause of skin and soft tissue infection, respiratory infections and 
IV drug users20. Small colony variants (SCV), subpopulation of  S.aureus 
that responded poorly to chemotherapy were identified (Seifert et al 2003). 
COAGULASE NEGATIVE STAPHYLOCOCCI (CONS) 
BSI due to CONS is mostly nosocomial but 8-10% are community 
acquired (Diekema et al 2003) . Over the past several years CONS was 
considered to be contaminants with little clinical significance. For the past 
four decades they have become important agents of human disease mainly 
in nosocomial condition dueto invasive procedures. CONS should be 
reported in BSI if two or more blood culture positivity is obtained10. 
S.epidermidis is the most common isolate among CONS other organisms 
occurring in BSI are S.hemolyticus, S.capitis, S.schleferi, S.warneri, 
S.saprophyticus and S.lugdunensis19. 
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ENTEROCOCCOUS SPP: 
These organisms are normal flora of GI tract and biliary tract, less 
commonly of vagina and male urethra. They are now considered important 
agent of human disease, because of their resistance to antimicrobial agents 
to which other streptococci are generally susceptible. They are second most 
common cause of nosocomial UTI and wound infection  and third most 
common cause of nosocomial bacteremias19. Due to the emergence of 
Vancomycin resistant enterococci26 (VRE), they are associated with serious 
super infections among patients receiving  broad spectrum antimicrobial 
chemotherapy. GI enterocccal  bacteremia usually results from GI tract and 
genitourinary tract infections. They are common cause of prosthetic valve 
endocarditis and constitute 5-20% of cases of endocarditis25 . Most common 
species is enterococcus faecalis21. 
OTHER GRAM POSITIVE ORGANISMS: 
S.viridans, S pneumonia, Listeria monocytogens andDiptheroids. 
GRAM NEGATIVE ORGANISMS: 
E.COLI, KLEBSIELLA AND OTHER ENTERO BACTERIACEAE: 
E.coli and Klebsiella spp., are the most common cause of both 
community acquired and nosocomial acquired bacteremias. 
 20 
 
Enterobacteriaceae accounts for 17% of all BSI and they are the 
second common cause of BSI next to CONS 19. 20% of hospitalized 
infections are due to Klebsiella pneumoniae which causes pneumonia. In 
healthy and immunocom promised patients non typhoid salmonella spp is 
important cause of BSI. Emegence of ESBL mostly due to E.coli and 
Klebsiella spp are clinically significant in management of sepsis. 
PSEUDOMONAS AEURGINOSA: 
BSI due to Pseudomonas aeurginosa is mainly nosocomial 
contributing significant morbidity and mortality of hospitalized patients. 
The prognosis is poor leading to life threatening complications and septic 
shock27. 
OTHER GRAM NEGATIVE PATHOGENS: 
Acinetobacter  spp.,  Haemophilus influenza, Neisseria species 
Fungi:  
Blood cultures remain an important diagnostic tool for disseminated 
fungal infections. Lysis centrifugation system is used now days to detect 
filamentous fungi causing sepsis. Among fungi, candida albicans is most 
frequently isolated from the blood leading to 10% of all nosocomial 
infections20. Candida infection is usually associated with malignancy, 
neutropenia, HIV/AIDS and other immunosuppressive conditions. 
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LABORATORY DIAGNOSIS OF BLOOD STREAM INFECTIONS  
Blood cultures are important diagnostic tool in patients with 
conditions that predispose to  BSI2. The growth of bacteria can be detected 
using manual techniques and automated methods. Many automated systems 
are available now which gives rapid results. Once growth is isolated, the 
organism is identified and tested for its susceptibility to various 
antimicrobial agents20. 
SPECIMEN COLLECTION & TRANSPORT: 
          Blood cultures are obtained using a sterile needle or syringe. About 5-
10 ml of blood should be drawn aseptically by single veni puncture, 
inoculated into the blood culture bottle containing medium and incubated. 
After18-24hrs of incubation the bottles are checked for presence of 
microorganisms.Blood cultures should not be obtained from indwelling 
intravascular catheters as there is greater risk of recovering skin organisms. 
If indwelling catheters are considered as source of BSI, then blood samples 
are collected from the catheter site.2 
SITE OF COLLECTION: 
Since there is increased incidence of bacteremia from bacteria that are 
part of normal skin flora such as Coagulase negative staphylococci, 
Corynebacteria and Bacillus species, appropriate asepsis should be 
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followed while collecting samples of blood. Blood is collected from 
peripheral vein (eg. cubital vein) .Contamination is more in femoral vein 
and arterial blood are of no use in recovering pathogens (Tenney et al, 
Vaisanen et al. 1985). The rate of contamination is higher from IV catheter 
blood samples since colonizers present in catheter gives false positive 
results. Infact catheter blood sample is useful when catheter related blood 
stream infection (CRBSI) is considered2. 
ASEPTIC PRECAUTION:  
The skin site over the vein is disinfected with 70% isopropyl alcohol 
in a circle rubbed vigorously. Then from the centre of the circle, 2% tincture 
of iodine (or povidone-iodine) is applied in circles and allowed to dry on the 
skin for at least 1 minute. Gloves should be used by the person collecting 
the blood. It is important to use both alcohol and iodine compound to 
disinfect the venipuncture site5,11. 
TIME OF COLLECTION 
Blood should be collected during febrile episodes or as soon as after 
the onset of fever and chills. It is also essential to collect blood samples 
before starting antibiotic therapy or end of a dosing interval29. 
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SPECIMEN VOLUME  
Adults: In adults with BSI the colony forming units (CFU) per 
milliliter of blood is very low. Therefore a sufficient sample volume of 
blood is required for the successful detection of bacteremia. The rate of 
isolation is greater, when more blood is cultured29. Results from a study 
suggested that the yield increases by 3.2% for every milliliter of blood 
cultured. For adults 10-20mL of blood per culture is required to increased 
the yield by 30 percent5. 
 
Children: It is unsafe to obtain large volumes of blood from children, 
particularly infants. Inspite of low level of bacteremia in infants and 
children it is safe to obtain as much as 4% to 4.5% of patients blood volume 
for culture. So the relationship between blood volumes for culture from 
infants and children by Baron and colleagues30 is shown in (Table 1). 
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Table 1 : Blood Volumes Suggested for Cultures from Infants and 
Children  
Weight of 
Patients 
Recommended volume of blood for culture (mL) 
Kg 
Total 
blood 
volume 
Culture 
No 1 
Culture 
No 2 
Total 
volume 
for 
culture 
% of 
total 
blood 
volume 
< 1 50-99 2  2 4 
1.1-2 100-200 2 2 4 4 
2.1-12.7 > 200 4 2 6 3 
12.8-36.3 > 800 10 10 20 2.5 
> 36.3 > 2200 20-30 20-30 40-60 1.8-2.7 
 
NUMBER OF BLOOD CULTURES  
The rate of detection increases with the number of blood cultures .The 
first blood culture should be obtained at the same time and inoculated into 
two different media and at two different temperatures . The second set of 
culture should be obtained in the same way & this increases the sensitivity 
rate to 99%4,5,8,30. There is no current recommendation for ideal time 
difference between two blood culture10. 
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CULTURE MEDIA: 
The media used for Blood cultureshould be nutritionally enriched 
with Tryptic or Trypticase soy, brain heart infusion, Columbia Agar and 
Brucella broths are used commonly. These commercially available media 
contains the anticoagulant Sodium ployanethol sulfonate (SPS, Liquoid) 
(Wilson et al. 1994), 0.025% to 0.05% concentration19. Bacteria cannot 
survive well in the clot and so anticoagulants are used. SPS inactivates 
neutrophils &inhibit antibiotics including Streptomycin, Kanamycin, 
Gentamycin, and Polymyxin. The side effects of SPS is that it inhibits the 
growth of certain bacteria like Neisseria gonorrhoea, Neisseria 
meningitidis, Peptostreptococcus anaerobius2. This inhibitory effect of SPS 
can be neutralized by addition of gelatin (1%) to the medium. The use of 
resin in blood culture media significantly increases the recovery of 
pathogens such as members of the family Enterobacteriaceae, Enterococcus 
spp, S.pneumoniae and S. viridans. Antimicrobial agents normally present 
in human blood are neutralized by adding adsorbents such as resins, 
activated charcoal and fuller’searth(Peterson et al 1983)19. 
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TRANSPORT 
Refrigeration of blood cultures are not recommended. Rapid 
transportation of blood cultures and immediate processing in the laboratory 
is done for appropriate recovery of pathogens31. 
SAMPLE PROCESSING 
Processing of blood cultures includes incubation, gram staining and 
subcultures.There are manual and automated blood culture systems 
available for processing. 
SYSTEMS FOR PROCESSING BLOOD CULTURES: 
MANUAL BLOOD CULTURE SYSTEMS: 
The  two  commercially  available  manual  Blood  culture  systems  
are  variations  of  classic  biphasic  media  bottles  known as Castenada  
bottles.  They  are 
The Oxoid Signal System  : 
                 The Oxoid (Ogelensburg, N4) signal system is a single bottle  
blood culture system where the bacterial growth is determined by the 
production of CO2.The blood culture bottle is connected to a second  plastic  
chamber, called signal  chamber  fitted  at  the  bottom  with  a  long  needle.  
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Bacterial growth and metabolism produces CO2. Weinstein et al  designed  
new  bottle  with  increased  head – gas  space  which  increased  the yield  
of  organisms32. 
BBL Septi – Check Blood  Culture System  : 
The  Septi-Chek  biphasic  agar  slide system (BD  Diagnostic system,  
sparks, MD )  uses  blood  culture  bottle  containing  brain heart infusion 
broth  or trypticase Soy broth33. The slide contains paddle with agar surface. 
After inoculation, the plastic contained “slide”  is  screwed  on .The agar  
surface  is  flooded with  the  broth  for  few  minutes  and  then  again  
placed  upright  for  continuous  incubation. The  bottle  is  inverted  at  
regular  intervals  and sub cultured after incubating  at  37  c  for   4  - 6hrs  . 
LYSIS CENTRIFUGATION  BLOOD  CULTURE  SYSTEM  :  
(Wampole Isostat  / Isolator  Microbial System) 
The  isolator  microbial  system (Wampole laboratories,  Princeton, 
NJ)  is a special  tube  contains  Saponin,a chemical  which  lyse  the white 
and red  blood  cells, Propylene glycol to decrease foaming, SPS as an 
anticoagulant,  EDTA  to chelate calcium and  a  small  amount   of  
Fluorochrome19.  This  is  an  alternative  blood culture method  used         
for  recovery  of  fastidious  (or)  slow  growing  organisms    (Bortonella 
henselae)19, Filamentous molds, dimorphic fungi, Malassezia furfur and 
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Legionella spp.,2 The mean recovery time of yeasts and  Histoplasma         
capsulatum  is  reduced  from  4.9  days  and 24.14 days  to  2.12  and  8  
days  respectively  with  the  isolator19. Increased rate of  contamination  is  
the  major  problem  with  isolator  system  and  it  can  be  decreased  by  
using  dry  agar  plates,  proper  disinfection  of  work  area  and  sample  
processing  in  a  Laminar  hood. 
EXAMINATION OF MANUAL SYSTEMS: 
Blood culture bottles are incubated at 37 C for 16to 18 hrs and 
examined for hemolysis, production of gas, or turbidity. Blind subcultures 
are made after 24 hrs of incubation and microscopic examination should be 
performed. For microscopic examination Gram stain or Acridine orange 
stains are used. Acridine orange stains detect 104 CFU/ml whereas Gram 
stain detects 105 CFU/ml34. Tierney et al reported 16.8 percent increase in 
the detection of bacteremia using acridine orange stain while the broth is 
macroscopically negative. 
AUTOMATED AND COMPUTERIZED BLOOD CULTURE 
SYSTEMS 
The first automated system was BACTEC 460 (Becton dickinson), 
was introduced in the 1970s. The results are rapid and obtained within a day 
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After positive culture is obtained, bottles are removed for gram stain and 
sub culture2. 
BACT/ALERT MICROBIAL DETECTION SYSTEM: 
This system contains CO2 sensitive chemical sensor separated by 
unidirectional CO2 permeable membrane which is bonded to the bottom of 
every bottle. The growth of microorganisms in the blood broth produces 
CO2, which makes the color sensor to turn from green to yellow. 
THE BACTEC9240/9120 BLOOD CULTURE SYSTEM: 
This system is similar toBACT/Alert but the only difference is the use 
of fluorescent, rather than spectral light for detecting change in CO2 
concentration. 
THE TREK ESP CULTURE SYSTEM 
The ESP blood culture system (TREK diagnostic system, Cleveland, 
OH) is different from the above two systems by  
1. The CO2 production, monitored manometrically.  
2. Monitoring both gas consumption and production.  
3. In addition to CO2 production H2 and O2 concentration changes 
are also monitored (testing multiple gas production27). 
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ANTIMICROBIAL SUSCEPTIBILITY TESTING: 
                 After identification of the causative organisms the management 
of BSI includes early and appropriate treatment by antimicrobial therapy. 
Antibacterial susceptibility testing: 
Antibiotic sensitivity testing was done by Kirby Bauer disc diffusion 
method, using 0.5 McFarland’s turbidity on Mueller Hinton agar plates 
Commercially available Hi-media antibiotic discs are used. 
Antifungal susceptibility testing: 
 It was performed on Mueller Hinton agar plate supplemented 
with 2% glucose and 0.5 µg/ml methylene blue. Commercially available Hi-
media antifungal discs are used. 
MANAGEMENT OF BSI 
According to Bayer et al, the general treatment principles to be 
followed:  
1. High dose parenteral antimicrobial therapy is recommended to reach 
sustained antibacterial activity; 
2. Prolonged administration of antimicrobial therapy is required to 
prevent relapse;  
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3. Bactericidal agents are generally preferred over bacteriostatic agents; 
4. Combination therapy is recommended to produce a rapid bactericidal 
effect. The choice of antibiotics for the treatment is governed by 
susceptibility of the causative organism. Determination of minimal 
inhibitory concentration is recommended to define optimal treatment. 
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MATERIALS AND METHODS 
STUDY PERIOD: 
This is a cross sectional study undertaken over a period of 1 year from 
October 2010 to Sep 2011. 
STUDY PLACE: 
The study was carried out at the Institute of Microbiology, Madras 
Medical College, RGGGH, Chennai-3. 
ETHICAL CONSIDERATIONS: 
This study was reviewed and approved by Institutional ethical 
committee Madras Medical College and RGGGH, Chennai-3. Informed 
written consent was obtained from the study population or their guardians 
after providing full explanation of the study. All patients satisfying the 
inclusion criteria were documented and interviewed by structured 
questionnaire. 
STATISTICAL ANALYSIS: 
Statisticalanalysis were carried out using statistical package for social 
science (SPSS) and Epi-Info software by a statistician. The proportionaldate 
of thiscross sectional study were tested using pearson’schi square analysis 
test and Binomial proportion test. 
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STUDY GROUP: 
Blood samples from inpatients admitted in IMCU of RGGGH, 
Chennai. 
SAMPLE SIZE: 
All consecutive septicaemic patients admitted in IMCU during the 
study period. 
INCLUSION CRITERIA: 
1. Patients above 15 yrs2of age group. 
2. Patients with known Sepsis or strong clinical suspicion of sepsis 
3. Signs of SIRS16. 
4. Dysfunction of atleast one organ system15. 
SIRS CRITERIA: 
SIRS criteria and proven (or) suspected infection is called sepsis. The 
criteria includes3 
i. Temperature > 38˚C or < 36˚C 
ii. HR >90/min 
iii. RR >20/min 
iv. WBC count > 12,000/cu.mm or < 4000cells /cu.mm or 10% 
immature (band) neutrophil forms.  
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All patients satisfying the inclusion criteria were only documented 
and were assigned serial numbers. Patients were interviewed by structured 
questionnaire and their hospital records were used to know about their past 
medical conditions. They were followed up prospectively until discharged 
or after admission. 
EXCLUSION CRITERIA: 
1. No clinical suspicion of sepsis  
2. Prior antibiotic administration 
CASE DEFINITION: 
SEPSIS:  
SIRS with presumed or confirmed infectious process. This is the host 
response to a microbiological event. 
BACTEREMIA:  
BSI was diagnosed when a blood culture grew an organism with      
(2˚ BSI) or without (1˚ BSI) any obvious focus of sepsis – True bacteremia 
was considered when one or more blood cultures showed a recognized 
pathogen. 
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COMMUNITY ACQUIRED BACTEREMIA is defined if the first 
positive blood culture was obtained before or within 48 hrs of 
hospitalization and not associated with any procedure performed after 
hospital (or) ICU admission. 
NOSOCOMIAL BLOOD STREAM INFECTION is defined in a 
patient with significant blood culture positive for a bacteremia (or) fungus 
that is obtained more than 48 hrs after admission to the hospital and is 
directly related to invasive procedures on admission to the hospital            
(eg Urinary catheterization or insertion of IV line). 
The source of BSI was identified by the isolation of same pathogenic 
organism from both the source and the blood. 
The following definitions were used to categorize the source of 
bacteremia. 
1. Pneumonia is defined as the presence of an acute illness associated 
with respiratory symptoms and an infiltrate on chest roentgenography. 
2. Cellulitis is considered if physical finding of an erythema, tenderness, 
and warmth within a focal distribution is found. 
3. Urinary tract infection is considered if urine culture was positive 
and no other source of blood stream infection was found. 
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4. Endocarditis is defined as the demonstration of valvular vegetations 
on echocardiography, evidence of septic emboli or a new murmur and 
absence of any other source of septicaemia. 
5. Phlebitis is defined as an inflammation around a venous line from 
catheter in place for at least 72 hours &  positive blood culture in the 
absence of another source of bacteremia.  
6. Catheter related blood stream infection (CRBSI) is diagnosed 
when blood culture obtained from a peripheral vein and CVC grow 
the same organism and the CVC tip with quantitative bacterial counts 
>15 CFU (Maki method). 
Data collection:  
History was obtained from all patients and physical examination was 
also done. Information on antimicrobial therapy before admission was 
recorded. 
Sample collection and processing: 
Collection:  
Blood cultures were obtained using aseptic technique. Venipuncture 
sites were disinfected before phlebotomy with 0.5% Chlorhexidine solution 
followed by 70% isopropyl alcohol.11 
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Persons collecting the specimens should replace the needle used for 
the venipuncture with a fresh sterile needle before inoculating the blood into 
the culture bottles. It should be noted that they should hold needle by its 
butt, not the shaft and with sterile forceps or with gloved fingers.4 
Processing: 
1st set : For the purpose of  culture, 10-20ml of blood was collected (to get 
dilution of 1:5 or 1:10) and one half of the sample was inoculated into 
biphasic BHI (Brain heart infusion) media and other containing trypticase 
soy medium28. 
2nd  Set: Within 12 hours second set of samples were collected in the same 
way. 
Blood culture bottles were incubated at 37˚C for 24 hrs. Subcultures 
were done at the appearance of turbidity, gas production or the presence of 
microcolonies over the clot at 24 hrs, blind subcultures irrespective of 
turbidity or gas production is done at 48 hrs and final subculture were done 
at the end of 7th day, as follows: 
a. On 5% sheep Blood agar  aerobically  
b. On 5% sheep blood agar anaerobically  
c. On MacConkey agar aerobically  
d. Nutrient agar 
e. On Chocolate agar in CO2, all incubated at 37˚C for 24 hrs. 
f. Two Sabouraud’s dextrose agar tubes incubated at 25˚C & 37˚C. 
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IDENTIFICATION OF CULTURE: 
Morphology of colonies grown on blood agar, MacConkey agar, 
Chocolate agar at 18-24hrs were noted and isolates were identified by  
1. Gram stain – to identify whether gram positive or gram negative 
organisms. 
2. Gram positive cocci were proceeded with calatase and coagulase 
tests. 
3. Hanging drop done to find out motile and non-motile organisms. 
4. Preliminary tests like oxidase, catalase tests were also performed. 
5. Members of the species were identified based on biochemical 
parameters using IMVIC reactions and  other sugar fermentation 
tests. 
Antimicrobial susceptibility tests: 
Antimicrobial susceptibility testing of the bacterial isolates were 
performed using Kirby –Bauer disc diffusion method on Mueller – Hinton 
agar and zone diameters were interpreted according to the CLSI 
guidelines.36 
Medium used : MHA (Mueller – Hinton blood agar) plate 
Inoculum  : 0.5 McFarland turbidity, lawn culture 
Incubation  :  37˚C ambient air, incubated for 16-18 hrs 
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Preparation of Inoculum: 
About 4-5 colonies of similar morphology were picked up with the 
help of straight wire and inoculated in 5ml of peptone water, and it is 
incubated for 3-5 hrs which gives 0.5 McFarland’s turbidity.2 A sterile 
cotton swab was taken and dipped into it and pressed firmly against the wall 
of the test tube so as to remove the excess broth from the swab. 
Mueller Hinton agar plate was dried and swabbed in three directions 
approximately 60˚ each time to ensure complete distribution of the 
inoculums over the entire plate. The antimicrobial discs were dispensed on 
the Mueller Hinton agar plate using dispenser and pressed down to give 
complete contact with the surface of the agar. The discs were distributed 
evenly on the plate and the distance should not be closer than 24 mm from 
centre to centre. Not more than 6 discs were placed in a single plate37. After 
an incubation period of 16-18 hrs each plate was examined. The diameter of 
the zones which gave complete inhibition was measured. The diameters of 
zones of inhibition was interpreted according to CLSI standards for each 
organism. 
The following standard strains were used  
1. Staphylococcus aureus – ATCC 25923 
2. Escherichia coli – ATCC 25922 
3. Pseudomonas aeruginosa – ATCC 27823 
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The panel of antibiotics included in the antimicrobial sensitivity 
testing for Gram negative bacilli were (Himedia, Mumbai). 
INTERPRETATIVEZONE DIAMETERS FOR GNB 
Antimicrobial 
Disc 
content 
Inhibition zone in mm 
Resistance Intermediate Sensitive 
Amikacin 30 µg 14 15-16 17 
Cefepime 30 µg 14 15-17 18 
Ceftazidime 30 µg 14 15-17 18 
Cefotaxime 30 µg 14 15-22 23 
Ciprofloxacin 5 µg 15 16-20 21 
Gentamicin 10 µg 12 13-14 15 
Imipenem 10 µg 13 14-15 16 
Ofloxacin 5 µg 12 13-15 16 
Piperacillin/ 
Tazobactam 
100/10 µg 17 18-20 21 
 
 41 
 
The panel of antibiotics included in the antimicrobial sensitivity 
testing for Gram positive cocci are given below (Himedia ,Mumbai). 
INTERPRETATIVE ZONE DIAMETERS FOR GPC 
Antimicrobial Disc content 
Inhibition zone in mm 
Resistance Intermediate Sensitive 
Amikacin 30 µg 14 15-16 17 
Cefepime 5 µg 15 16-20 21 
Ceftazidime 1.25/23.75 µg 10 11-15 16 
Cefotaxime 30 µg 12 13-17 18 
Ciprofloxacin 2 µg 14 15-20 21 
Gentamicin 10 units 28 - 29 
Imipenem 5 µg 16 17-19 20 
Ofloxacin 15 µg 13 14-22 23 
Piperacillin/ 
Tazobactam 
1µg 10 11-12 13 
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Macrobroth dilutionmethod:38 
Minimum inhibitory concentration (MIC) for detecting Vancomycin 
resistance20. 
1. Culture media: Cation adjusted Mueller Hinton broth. (pH 7.2-7.4). 
2. Preparation of stock solution: 
Antibiotic stock solution is prepared using the formula35 
= 1000 /p x V x C = w 
Where p = antibioticpotency in relation to the base, (For Vancomycin, 
p=950/1000 mg; Hi-media).  
V= volume of the stock solution that is to be prepared (10ml) 
C= final concentration of the antibiotic stock solution (1024µg/ml) 
W=weight of the antibiotic that is to be dissolved in the volume V 
3. Scheme of preparing dilution of antibiotics  
 Arrange two rows of sterile test tubes in the rack (1 row for the test & 
2nd for ATCC control)  
Using sterile syringe transfer 2ml of Mueller Hinton broth to the 
storage vial containing the working stock solution (129 µg/ml 
concentration). From this transfer 1ml to the first tube in each row.  
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 Now thereis 2ml of diluted antibiotic remaining  in the storage vial . 
Using syringe add 2ml of MH broth to the 2ml of left over antibiotic 
in the, storage vial mix and transfer 1ml to second tube in each row.  
 Repeat this procedure till the 8th tube  
 Place 1 ml of the antibiotic free broth in the last tube in each row 
(growth control)  
 The sterility controls for the antibiotic solution is kept.  
4. Inoculum preparation for the test and ATCC control and 
incubation: 
 Take 9.9 ml of MH broth in a storage vial 
 Add 0.1 ml of 0.5 McFarland turbidity matched test organism broth  
 Mix well, transfer 1 ml of inoculum using 2 ml syringe to each tube 
containing antibiotic dilutions and also to the control tube. 
 Similarly repeat the procedure for ATCC control strain  
 Incubate the rack at 37ºC – overnight  
 Observe the MIC of ATCC control strain, If it is out of the sensitive 
range, the test is invalid  
 Read for the test organism  
 The lowest concentration of the antibiotic in which there is no visible 
growth will be the MIC for the drug & for the test organism. 
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MINIMUM INHIBITORY CONCENTRATION TEST : 
E-Test for GNB : (Epsilometer test) Triple ESBL Detection Ezy MIXTM 
strip, Hi-media, Mumbai. 
It is a unique Phenotypic ESBL detection strip commercially 
available which is coated with mixture of 3 different antibiotics with & 
without clavulanic acid on a single strip in a concentration gradient manner. 
The upper half has Ceftazidime, Cefotaxime and Cefepime (Mixture +) 
Clavulanic acid & Tazobactum with higher concentration tapering 
downwards, whereas lower half is similarly coated with Ceftazidime, 
Cefotaxime and Cefepime (Mixture) in a concentration gradient in reverese 
direction. 
Quality Control : 
 ATCC E.coli 25922 
Procedure:  
 A Standard inoculum size of ESBL detecting strain was swabbed on 
MHA plate with a sterile non –toxic cotton swab, streak the entire agar 
surface of the plate with the swab 3 times, turning the plates at 600 angle 
between each  streaking. Remove the strip with applicator provided and 
place the strip at a desired position on agar plate swabbed with test culture. 
Then the plate was incubated at 35-370 for 18 hours. 
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Interpretation : 
 The Value corresponding to the point of intersection was taken as end 
point.  
For ESBL positive Strain Mix/Mix+ ≥ 8 
For ESBL negative Strain Mix/Mix+ ≤ 8 
 
A. Extended spectrum β lactamases (ESBL) detection methods35,2,19,28 : 
1. Screening method : 
Isolates of gram negative bacilli showing the following resistance 
pattern were considered to be possible ESBL producing strains34. 
Antibiotic 
Zone diameter for possible ESBL producing 
strain 
Ceftazidime (30 µg) < 22mm 
Cefotaxime (30 µg) < 27mm 
Ceftriaxone (30 µg) <25mm 
Aztreonam (30 µg) < 27mm 
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2. CLSI phenotypic confirmation method:  
With the help of a sterile bacterial loop, 3-5 identical colonies were 
selected from a fresh overnight grown culture and inoculated into 5 ml of 
nutrient broth &incubated at 35ºC for 2-4 hrs and matched for turbidity with 
0.5 McFarlands standard. Lawn culture of the test organism was made on to 
MHA plate. Antibiotic disc Ceftazidime (CAZ 30µg) and 
Ceftazidime/Clavulanic acid (CAZ/CA 30 µg/10mg) were placed onto the 
plate and incubated at 35ºC overnight. An increase in zone diameter of         
≥ 5mm for Ceftazidime tested in combination with Clavulanic acid versus 
its zone when tested with Ceftazidime alone confirmed as ESBL producing 
organism34,54. 
3. Double disk diffusion synergy test: 
 In this test of third generation Cephalosporin discs and Augmentin    
(20 µg/10 µg) (Himedia, Mumbai) discs were kept 30mm apart from centre 
to centre on inoculated Muller-Hinton Agar (MHA). A clear extension of 
the edge of the inhibition zone of cephalosporin towards Augmentin disc 
was taken as positive for ESBL production. 
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B. AMPC β Lactmases detection methods: 
1. Screening method: 
A 0.5Mcfarland of the test isolate was swabbed on MHA plate and 
disc of Cefotaxime (3µg), Ceftazidime (30µg) were placed adjacent to 
Cefoxitin (30µg) disc at a distance of 20 mm from each other. After 
incubation, isolates showing blunting of Ceftazidime or Cefotaxime zone of 
inhibition adjacent to Cefoxitin disc or showing reduced susceptibility to 
either of the above drugs and Cefoxitin were considered as screening 
positive and selected for detection of AmpC β lactamases39. 
2. AmpC Disc test: 
A lawn culture of E.coli ATCC 25922 were prepared on MHA plate. 
Sterile discs (6 mm) moistened with sterile saline (20 µl) was inoculated 
with several colonies of test organism. The inoculated disc was then placed 
adjacent to Cefoxitin disc (almost touching) on the inoculated plate. The 
plates were incubated overnight at 35ºC. The appearance of flattening or 
indentation of the Cefoxitin inhibition zone in the vicinity of the test disc is 
taken as positive. A negative test showed an undistorted zone. 
 
 
 48 
 
C. Metallo β Lactamase (MBL) Detection Methods: 
1. Imipenem – EDTA disc method: 
A 10 µg imipenem disc (Hi Media) which contains 750 µg of EDTA 
solution was used. The inhibition zone with imipenem–EDTA disc were 
<14 mm for the MBL negative isolates and > 17 mm for MBL positive 
isolates. 
2. Imipenem – EDTA combined disk test: 
The test organism was inoculated onto MHA plate. Imipenem (10µg) 
and 10 µg Imipenem disc containing 750µg of EDTA solution were placed 
on the plate and incubated overnight. If the increase in inhibition zone with 
Imipenem – EDTA disc is ≥ 7mm than the Imipenem disc alone, it was 
considered MBL positive40. 
D. Detection of methicillin resistance in staphylococcus aureus: 
1. Disc diffusion method: 
Colonies isolated from culture plate were suspended directly into 
broth, vortexed to reach 0.5 McFarlands standard. A lawn culture of the 
Staphylococcal colonies was made on the MHA plate and Oxacillin disc 
was applied. Incubation was done at 35ºC for 24 hours in ambient air. 
According to CLSI criteria with 1µgOxacillindisc, diameters of ≤ 10, 11-
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12mm, ≥ 13mm corresponded to categorization as resistant, Suscepible dose 
dependant or susceptible. With 30µg Oxacillin disc diameter of ≤ 19 or         
≥ 20mm corresponded to resistance or susceptibility.2 
2. Oxacillin screen agar: 
 Oxacillin screen agar test was performed by direct colony suspension 
method and adjusted to match with 0.5MacFarland turbidity standard. The 
suspension was inoculated on Mueller-Hinton agar containing 4%NaCl and 
with 6µg/mlOxacillin40. Plates were incubatedat 35ºC for 24 hours. Any 
growth on the plate containing Oxacillin was considered as resistant to 
Methicillin. 
PROCESSING OF FUNGI: 
Growth in SDA is further processed by following tests: 
The SDA slopes were examined after 48 hrs, 96 hrs, 5 days, 7 days, 
14 days and one month for the appearance of yeasty or mouldy growth.2 
Gramstain 
Gram positive oval budding yeast cell with presence or absence of 
pseudohyphae. 
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Germtube test: 
A loopful of yeast like cells obtained from SDA was suspended in 
0.5mlof human serum.  After incubation for 1-2 hrs, one or two drops of the 
suspension was placed on a clean microscopic glass slide and covered with 
coverslip and focussed under low and high power objective  to see the 
characteristic germ tube formation. 
CHROM agar (HIMEDIA) 
A single colony was taken from sabouraud’s dextrose agar and was 
streaked on chrom agar plate. Thenthe plates were incubated at 37˚C for 
48hrs. After incubation, the plates were observed for characteristic coloured 
colonies of candida.  
Cornmeal agar: 
Another method of identification of C albicans is based on formation 
of chlamydospores on cornmeal agar. 
A single colony from SDA was inoculated onto plate of cornmeal 
agar containing 1% Tween 80 and trypan blue. Three parallel streaks of 
about half an inch apart holding the inoculated wire about 45˚ angle and the 
area where cuts made were covered with sterile coverslips and incubated at 
22˚C for 24hrs. After incubation the areas where cuts were made onto the 
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agar41 were examined under the microscope for the presence of 
blastoconidia, pseudohyphae or truehyphae and chlamydospores2. The 
candida species were identified according to the morphological features on 
the corn meal tween 80 agar under the microscope.  
Carbohydrate fermentation test: 
About 0.2 ml of saline suspension of the yeast colonies were 
inoculated onto the different sugar media that contain durhams tube. The 
concentration of sugar 2% with bromothymol blue indicator and the 
different sugar used were glucose, lactose, sucrose, maltose respectively. 
The tubes were incubatedat 30 C for 48 to 72 hours41. After incubation 
period, the tubes were observed for acid and gas production. 
Antifungal susceptibility test: 
 The antifungal susceptibility test were done by 2 methods 
1. Disc diffusion method as per M 44-A document36. 
2. Microbroth dilution method, as per the CLSI guidelines on antifungal 
Susceptibility testing in M 27-A2 document37. 
Inoculum preparation: 
 About five clonies of same morphology of each atleast 1mm in 
diameter from 24 hr old cultures of candida spp. were picked up and 
 52 
 
inoculated in 5ml sterile saline. The suspension was then adjusted 
spectrophotometrically at 530nm which matched the 0.5 McFarland’s 
barium sulphate standard. This gives the inoculums size of 1 x 106 to 5 x 
106cfu/ml. The same inoculum was used for both methods.  
Quality control : 
Candida albicans ATCC 90028. 
Disc diffusion method: 
It was performed on MHA plate supplemented with 2% glucose and 
0.5 mg/ml Methylene blue2 .Anti fungal susceptibility testing was carried 
out following M44-A-guidelines for clinical laboratory standards institute 
(CLSI) guidelines using antifungal discs. 
Microbroth dilution method: 
Medium36: 
RPMI 1640 medium with glutamine, without bicarbonate in MOPS 
(3N- Morpholino propane sulphonic acid), buffer sterilized by membrane 
filtration. 
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Antifungal stock solution:  
The MIC range of antifungal agents used were 
• Amphotericin B : 0.03-16 µg/ml 
• Fluconazole : 0.125 to 64 µg/ml 
Fluconazole was dissolved in sterile distilled water whereas 
Amphotericin B was dissolved in DMSO. From the working dilution, 
the desired concentrations were prepared. 
Procedure: 
This test was performed in a sterile, disposable 96 well microtitre 
plate using standard RPMI 1640 medium. After 48 hours of incubation at 
35oC the results are interpreted. 
Interpretation:  
For Fluconazole, isolates with MIC 8µg/ml were considered 
susceptible values, between 16-32 µg/ml dose dependent susceptible and 
those 64µg/ml resistant. Due to the lack of definite break points for 
Amphotericin B, isolates showing an MIC of < 1.0 µg/ml were taken as 
susceptible and those with MIC > 1 µg/ml were considered as resistant37. 
The end point for Fluconazole was the lowest concentration in which 
permanent decrease in turbidity was observed. For Amphotericin B, the end 
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point was defined as the lowest concentration in which an optically clear 
well was observed. 
Interpretation of Results: 
A culture was considered significant when a pure isolate was isolated 
from a pair of blood culture bottles. The blood samples inoculated in BHI 
media were discarded after 7 days. Fungal blood cultures were held for 21 
days before being reported as negative20. 
To be a probable pathogen: 
1. Growth of same organism in repeated cultures obtained either at 
different times or from different anatomical sites.  
2. Growth of organisms from suspected case of Endocarditis2. 
3. Isolation of commensal bacteria from patients suspected to be 
bacteremic. (immunocompromised pts or those having prosthetic 
valves19). 
4.  Growth of same organism from culture IV Catheter tip culture& the 
peripheral line culture confirms CRBSI. 
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RESULTS 
A total of 150 individuals were enrolled in this study, conducted 
during October 2010 to September 2011 at Institute of Microbiology, 
Madras Medical College, Chennai. From 150 patients blood samples from 
all the patients were collected and subjected to culture in Brain Heart 
Infusion Biphasic medium and Trypticase Soy broth.  
 
 
 
 
 
 
 
 
 
 
 
  
Table 2: Age Distribution of Cases (n=150)
Age 
No. of cases
Male
16-20 
21-30 18
31-40 23
41-50 35
51-60 15
>61 12
Total 112
 
Majority of the male cases belong to the age group of 41 to 50 yrs 
(31.33%) and the next commonest age group is 31 to 40 yrs (19.33%). 
Males outnumbered female in this study.
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Total 
 Female 
9 2 11 
 4 22 
 6 29 
 12 47 
 11 26 
 3 15 
 38 150 
 
 
Percentage 
% 
7.33 
14.66 
19.33 
31.33 
17.33 
10 
100 
 
  
Table 3 : 
Sex 
Male 
Female 
Total 
 
75% of cases were males and 25% of cases were females. Males 
outnumbered females in this study.
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Sex Distribution of Cases (n=150)
No. of Cases Percentage %
112 
38 
150 
 
 
 
74.7 
25.3 
100 
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Table 4 : Correlation between Clinical Symptomatology and  
BSI (n-150) 
S.No Clinical Features Cases (n=150) % 
No. of Pts 
with BSI % 
1. Fever 150 100 63 100 
2. Respiratory Distress 18 12 12 19.04 
3. Ascites / Pedaledema 16 10.7 2 3.17 
4. Icterus 16 10.7 3 4.76 
5. Anemia 65 43.33 24 38 
6. Lymphadenopathy 18 12 8 12.7 
7. Neurological Symptoms* 12 8 9 14.28 
8. Urinary Symptoms 16 10.6 14 22.22 
9. Skin Lesion 15 10 9 14.28 
10. Tubercular Infection 25 16.66 10 15.87 
 
* Includes Headache, neck stiffness, hemiparesis, hemiplegia. 
Fever (100%) was present in all cases and blood culture positive 
cases. Anemia (43%) was the second presenting symptoms in patients with 
BSI. Urinary Symptoms (22%), TB infection (15.8), Respiratory Distress 
(19%) were next commonest symptoms in the descending order.  
 
 
  
 
Correlation between Clinical Symptomatology and BSI 
 
 
 
 
 
 
59 
 
 
 60 
 
 
Table 5 : Results of Blood Culture (n=150) 
 
Blood Culture No. of cases % 
Positive 63 42 
Negative 87 58 
 
Blood culture was found to be positive in 63 (42%) cases. 
 
 
 
 
42
58
Results of Blood Culture
Positive
Negative
  
 
Table 6 : Age Distribution of BSI Positive Cases (n=63)
Age 
No. of cases
Male
16-20 
21-30 
31-40 
41-50 16
51-60 
>61 
Total 47
  
In BSI positive cases 47 were males and 16 were females. Most common 
age group associate with BSI was 41 to 50 years (33.33%) and the next 
common age group was 31 to 40 years (19.04%).
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Total 
 Female 
4 1 5 
6 2 8 
9 3 12 
 5 27 
6 4 10 
6 1 7 
 16 63 
 
Percentage 
% 
7.93 
12.69 
19.04 
33.33 
15.87 
11.11 
100 
 
 
 
 
 
  
0
5
10
15
20
25
30
35
18.66
33.33
Comorbid illness in septicaemic patients  
Table 7: Comorbid illness in septicaemic patients 
S.No Comorbid illness
1. Hypertension
2. Diabetes Mellitus
3. Asthma/COPD
4. Cirrhosis
5. Known heart disease
6. Renal disease (acute, 
chronic)
7. Previously treated TB
8. Auto immune disorder
 Total
 
Most of the cases of Septicaemiais associated 
(33.33%). Hypertension is associated with 
Asthma/COPDwith 13% and Renal disease associated with 
62 
13.33
4
10
12.67
8
Percentage  in cases
 
 Male Female 
 20 8 
 32 18 
 18 2 
 6 - 
 14 1 
 
18 1 
 12 - 
 - 1 
 112 38 
with Diabetes Mellitus 
18.66% of cases, 
12% of cases.
0.6
Total % 
28 18.66 
50 33.33 
20 13.33 
6 4 
15 10 
19 12.67 
12 8 
1 0.6 
150 100 
 
  
Table 8 : Epidemiology of BSI Positive Cases  (n=63)
 
 
Community acquired
Nosocomial acquired
 
55.6% of BSI positive cases were 
were community acquired.
 
63 
 
No. of cases 
(n=63) 
 28 44.4%
 35 55.6%
nosocomial acquired and 44.4% 
 
% 
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Table 9 :Organisms isolated by Blood Culture in Septicaemic Patients 
(n=63) 
Organisms 
No. of cases 
(n=63) 
% 
GRAM POSITIVE COCCI 24 38.09 
Staphylococcus epidermidis 9 14.28 
Staphylococcus schleiferisubsp.schleiferi 3 4.76 
Staphylococcus aureus 10 15.87 
Enterococcus fecalis 2 3.17 
GRAM NEGATIVE BACTERIA 35 55.55 
Pseudomonas aeruginosa 11 17.46 
Klebsiella pneumonia 10 15.87 
Escherichia coli 10 15.87 
Acinetobacterspp 2 3.17 
Proteus mirabilis 1 1.58 
Citrobacterkoseri 1 1.58 
FUNGI 4 6.34 
Candida albicans 2 3.17 
Candida tropicalis 2 3.17 
Total 63 100 
 
Total Culture positive cases were 63.Gram positive cocci were 24 
(38.09%) , Gram negative bacilli were 35 (55.55%) & Candida spp was 
isolated in 4 (6.34%) of cases. 
  
Organisms isolated by Blood Culture in Septicaemic Patients
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Table 10 :Antimicrobial Susceptibility of Gram positive Bacteria 
Causing BSI in IMCU patients 
S.
No 
Antibiotics  Staphyloc
occus 
aureus 
(n=10) 
Staphyloc
occus 
epidermid
is 
(n=9) 
Staphylococcus 
schleiferisubsp.
schleiferi 
(n=3) 
Enteroco
ccus 
fecalis 
(n=2) 
No. % No. % No. % No. % 
1 AmoxycillinC
lavulanic acid 
5 50 4 44.4 2 66.7 1 50 
2 Amikacin 8 80 8 88.9 1 33.3 1 50 
3. Cephalexin 3 30 2 22.2 2 66.7 - - 
4. Cotrimoxazol
e 
3 30 4 44.4 2 66.7 1 50 
5. Ciprofloxacin 5 50 7 77.8 1 33.3 1 50 
6. Erythromycin 6 60 3 33.3 2 66.7 1 50 
7. Oxacillin 3 30 3 33.3 1 33.3 0 - 
8. Penicillin 3 30 3 33.3 2 66.7 1 50 
9. Vancomycin 
(MIC) 
10 100 9 100 3 100 1 50 
 
All GPC showed 100% sensitivity for Vancomycin except 
Enterococcus faecalis. 
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Table 11 : Antimicrobial Susceptibility of Gram Negative Bacteria 
Causing BSI in IMCU patients 
Antibiotics  Pseudomonas 
aeruginosa 
(n=11) 
Escherichia 
coli (n=10) 
Klebsiella 
pneumonia 
(n=10) 
Proteus 
mirabilis 
(n=1) 
Citrobacterkoseri 
(n=1) 
Acinetobacter 
spp (n=2) 
No. % No. % No. % No. % No. % No. % 
Ciprofloxacin 7 63.6 6 60 7 70 1 100 0 0 1 50 
Cefotaxime - - 3 30 2 20 0 0 1 100 - - 
Ceftazidime 5 45.4 3 30 2 20 - - - - - - 
Ofloxacin 6 54.5 5 50 4 40 1 100 0 0 0 0 
Amikacin 6 54.5 9 90 8 80 1 100 0 0 1 50 
Gentamycin 5 45.4 9 90 5 50 1 100 0 0 1 50 
Cefoperazone-
sulbactum 
6 54.5 6 60 4 40 0 0 0 0 1 50 
Imipenam 9 81.8 10 100 10 100 1 100 1 100 2 100 
 
All GNB showed high level resistance to third generation 
cephalosporin. All GNB except Pseudomonas aeruginosa showed 100% 
sensitivity for Imipenem. 
  
Table 12 :Detection of Methicillin Resistance among Gram positive 
Cocci 
Method 
Staphylococcus 
aureus (n=10)
No. 
Disc diffusion 
method 
7 
 
7 isolates of staph.aureus (70%), 6 isolates of staph.epidermidis(66%) 
and 2 isolates staph.schleiferisubsp.schleiferi (66.7%) 
MRSA producing organisms.
66.7
Disc diffusion method
68 
 
Staphylococcus 
epidermidis 
(n=9) 
Staphylococcus 
schleiferisubsp.schleiferi
% No. % No.
70 6 66 2 
were found to be 
 
70
66
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus 
schleiferisubsp.schleiferi
 
(n=3) 
 % 
66.7 
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Susceptibility to 3rd GCS
Table 13 : ESBL screening test for gram negative organisms  
Organisms 
Susceptibility to 3rd 
Generation 
cephalosporins 
Resistant to 3rd 
Generation 
cephalosporins 
No. % No. % 
Klebsiella pneumoniae 
(n=10) 2 20 8 80 
Escherichia coli 
(n=10) 
3 30 7 70 
Pseudomonas 
aeruginosa (n=11) 5 45.4 6 54.5 
Acinetobacterspp 
(n=2) 
2 100 0 0 
 
8 isolates of Klebsiella pneumonia, 7 isolates of E.coliand 6 isolates 
of pseudomonas aeruginosawere found resistant to third generation 
cephalosporins (3rd GCS). 
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pneumonia 
80
70
Table 14 : Comparison of Screening tests with DDST & PCDDT
Organisms 
Klebsiella 
pneumonia 
(n=10) 
Escherichia coli 
(n=10) 
Pseudomonas 
aeruginosa (n=11)
Acinetobacterspp 
(n=2) 
 
23 isolates selected and subjected to confirmatory tests. 20 isolates 
were confirmed as ESBL producers by PCDDT. 
70 
Escherichia coli 
Pseudomonas 
aeruginosa Acinetobacterspp 
70
54.5
100
60
54.5
50
70
60
54.5
No. of screened isolates for ESBL
DDST
PCDDT
No. of screened 
isolates for 
ESBL 
DDST 
No. % No. % 
8 80 7 70 
7 70 6 60 
 
6 54.5 6 54.5 
2 100 1 50 
 
50
 
PCDDT 
No. % 
7 70 
6 60 
6 54.5 
1 50 
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31.74
22.22
17.46
7.93
6.34
4.76
9.52
0 5 10 15 20 25 30 35
Use of IV Catheter
Use of Urinary Catheter
Mechanical Ventilator
Post Surgical
Peritoneal dialysis / hemodialysis
Chemotherapy on Malignancy
Others
%
Table 15 : Predisposing Factors of BSI in IMCU Patients  
S.No Predisposing Cases (n=63) % 
1. Use of IV Catheter 20 31.74 
2. Use of Urinary Catheter 14 22.22 
3. Mechanical Ventilator 11 17.46 
4. Post Surgical 5 7.93 
5. 
Peritoneal 
dialysis / 
hemodialysis 
4 6.34 
6. Chemotherapy 
on Malignancy 3 4.76 
7. Others 6 9.52 
 
Intravenous catheters are associated with 31.7% and Urinary 
Catheters are associated with 22.22 % of BSI positive cases.  
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Table 16 :Source of infection in BSI positive cases 
S.No Source
1. IV catheter
2. Urinary tract
3. Respiratory system
4. GI tract (Bowel/Peritoneum)
5. Skin
6. Biliary tract
7. Others
8. Unknown
 
Intravenous catheters (25.4%) were the common source of infection 
associated with BSI followed by genitourinary sources (22.2%).
 
72 
11
5 4
1
8
4
Source of infection
 
 Cases (n=63) 
(CVC)  16 
 14 
 11 
 
5 
 4 
 1 
 8 
 4 
% 
25.4 
22.2 
17.5 
7.8 
6.3 
1.6 
6.3 
12.7 
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Table 16(a):  MINIMUM INHIBITORY CONCENTRATION 
TEST(MIC) for Vancomycin 
S.No. No. of Isolates 
Vancomycin 
Sensitive 
(MIC ≤ 2µg/ml) 
Resistant 
(MIC ≤ 2µg/ml) 
1. Staph aureus  (n=3) 0.5 - 
2. Staph aureus  (n=3) 1 - 
3. Staph aureus  (n=2) 2 - 
 
All 8 isolates are confirmed as Vancomycin Sensitive. 
Table 16(b):  MINIMUM INHIBITORY CONCENTRATION 
TEST(MIC) for GNB by E-Test. 
S.No. Isolate 
ESBL Positive 
Mix+/Mix ≥ 8 
ESBL Negative 
Mix+/Mix ≤ 8 
Ratio Value Ratio Value 
1. E.coli(n=2) R/0.064 15.625 - - 
2. 
Klebsiella 
Pneumoniae 
(n=1) 
R/0.032 31.25 - - 
 
Both E.coli and Klebsiella Pneumoniae were ESBL producers.
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Table 17 : Antifungal susceptibility tests by Disc diffusion method 
 
Fluconazole Itraconazole 
Sensitive Resistant Sensitive Resistant 
C.albicans (n=2) 2 0 2 0 
C.tropicalis (n=2) 0 2 0 2 
 
Candida tropicalis was found to be resistant to both fluconazole and 
Itraconazole. 
Table 18 : Antifungal Susceptibility Test by microbroth dilution 
method 
 
Amphotericin B Fluconazole 
Sensitive 
(MIC<1µg/ml) 
Resistant 
(MIC>1µg/ml) 
Sensitive 
(MIC<64µg/ml) 
Resistant 
(MIC>64µg/ml) 
C.albicans 
(n=2) 2 (100%) 0 2(100%) 0 
C.tropicalis 
(n=2) 2 (100%) 0 2(100%) 0 
 
Candida albicans and Candida tropicalis were susceptible to both 
Amphotericin B and Fluconazole. 
 
  
Table 19 : Analysis of clinical outcome / mortality of BSI in IMCU
Outcome 
Recovered 
Death 
Total 
 
35% of mortality rate was observed in BSI positive cases.
 
Analysis of clinical outcome / mortality of BSI in IMCU
 
0
10
20
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50
60
70
80
Recovered 
74
65.09
75 
Study group (n=150) BSI positive cases 
No. % No. 
111 74 41 
39 26 22 
150 100 63 
 
Death
26
34.92 Study group
BSI positive cases
 
(n=63) 
% 
65.09 
34.92 
100 
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Table 19 : Organism associated with mortality in BSI positive cases of 
IMCU (n=22) 
Total 
No.of 
deaths 
Organism isolated 
Pseudomonas 
aeruginosa 
Candida 
Staph. 
aureus 
CONS 
Klebsiella 
pneumonia 
E.coli 
22 8 (31.8%) 
3 
(13.6%) 
5 
(22.7%) 
3 
(13.6%) 
2 (9.09%) 
1 
(4.45%) 
 
In this study total deaths were 22 out of which 8 deaths (31.8%) was 
due to pseudomonas aeruginosa. 
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DISCUSSION 
Blood stream infections are a major cause of morbidity and mortality 
among patients in intensive care units (ICUs). The cause of infection in ICU 
is multifactorial and consequences depends on pathogens associated, source 
of infection in ICU underlying risk factors, timely intervention and 
appropriate treatment received. Hence this study was done to determine the 
bacteremia and fungemia in critical care setup, their source of infection and 
to determine the antimicrobial susceptibility pattern of the isolates from 
blood culture.  
In the present study, majority of the patients admitted in IMCU  with 
clinical signs of sepsis (under SIRS criteria) were in the age group of 41-50 
yrs. This results (Table 2)correlated with the study of prowle et al,critical 
care 200743 in which majority of the patients were from 49-73 yrs and the 
mean age is 61 yrs. In another study done by Van Gestel et al44, 2004, 
majority of the patients belonged to the age group 64 ± 15 yrs and the male : 
female ratio is 1:7:1. 
There was a male preponderance accounting for 75% in this study 
(Table3 ).  Orsi GB et al45 , also reported similar results in which male 
accounted for 64.8% & females accounted for 35.2% . In another study done 
by Derek et al 200146, Males (56.1%) outnumbered females. 
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Fever was presenting symptom in all 100% of cases in the present 
study. Since the patients with BSI  presenting clinically had other conditions 
like Urinary symptoms&Respiratory distresswere seen in 10% of 
cases,tubercular infection in 16% and neurological manifestations in 8% of 
patients. Anemia (43%) and icterus (10.8%) were consistently present in 
majority of cases as in (Table 4).  . 
Co-morbid conditions reported in this study were Respiratory disease 
(20%), renal disease (12%), Cirrhosis (gastroenterology) in (6%) and the 
independent risk factors were diabetes mellitus ( 33 %) and Hypertension 
(18 %). 
In this study, blood stream infections were found to be positive in 63 
of 150 cases. (Table 5). This correlated with the study of Jordivalles et 
al,200947, in which the prevalence rate of blood stream infection was 30 - 
40% of cases.   
Similar study by Pittet et al 200948&Rello et al 200948, also gave the 
prevalence of Bacteremia was 30%. Epidemiology of infection among 
culture positive BSI cases was shown in IMCU patients(Table 5)  
community acquired and nosocomial bacteremia were found to be 28 % 
&55 % respectively. 95% of the infection were monomicrobial as revealed 
by Garrouste Orgaset al49 2009 in their study. A recent nationwide 
surveillance study conducted  in United state hospital (scope) reported 
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that51% of Hospital acquired BSI occurred in ICUS.In another study by 
Stephane et al 200460, nosocomial  acquired BSI (60%)  is more common 
than community acquired BSI  (40%) and this correlated  with this study. 
Etiological agents were more commonly Gram negative bacteremia 
(55.55%) with Pseudomonas aeruginosa  being the most common isolate. 
Gram negative bacteremia (55%) is greater than gram positive bacteremia 
(35%).Gram negative bacteria isolated from the BSI culture positive cases 
include E.coli (15.87%), Klebsiellapneumoniae (15.87%),Acinetobacterspp 
(3.17%), Proteus mirabilis (1.58%), Citrobacterkoseri (1.58%). Gram 
positive bacteria accounted for 38.09 % of the isolates. Among gram 
positive bacteria coagulase negative Staphylococcus (CONS) was isolated 
in most samples (19%) than staphylococcus aureus  (15%). Among CONS, 
Staph epidermidis accounted for 14.28% and Staphylococcus schleiferi 
subspp. schleiferi accounted for 4.76% of total isolates. Fungal isolates 
isolated were candida albicans 3.17%  & candida tropicalis  3.17%.  
Jamal et al512009 found that most common isolate in BSI was 
Coagulase negative staphylococci (46%). In a similar study done by Rello 
et al &Valles et al 2009, CONS accounted for 49.8% and Pseudomonas 
aeruginosa accounted for 32.6 % of the BSI which correlated well with this 
study. Similarly Ogstonet al522009 reported coagulase negative 
staphytococcus to be the most common isolate.In a study conducted in 
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Brazilian hospital ICU & Staphylococcus aureus was found to be common 
isolate which was in contrast to our study. 
In the present study, aerobic gram positive cocci were isolated in 
38.09%, aerobic gram negative bacilli in 55.55%. This correlates with the 
study done by S Bhattacharya et al53, 2002 where GNB accounted for 56.2 
%& GPC accounted for 24%.  
From 63 BSI positive cases CONS was the most common pathogen 
isolated in 12 (19.8%) followed by Pseudomonas aeruginosa (17.55%).In 
coagulase negative staphylococci, S.epidermidis was isolated in (14.28%) of 
cases and S schleiferi subspp. Schleiferi was isolated in (4.76%) of cases. 
E.coli was isolated in (15.87%), Klebsiella in (15.87%), Acinetobacter in 
(3.17%), Proteus mirabilis in (1.58%), Citrobacter koseri in(1.58 %) of 
cases. Staphlococcus aureus was present in 38.09% of cases and 
Enterococcus faecalis in 3.17% of BSI positive cases 
Gram positive bacteria showed 100% sensitivity to Vancomycin. All 
Enterobacteriaceae showed 100% sensitivity to Imipenem. 
The commonest bacteria isolated in this study, CONS showed 100% 
sensitivity to Vancomycin, 80% sensitivity to Amikacin, 77% to 
ciprofloxacin 60% sensitivity to Erythromycin. 
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The second common isolate among GPC was S.aureus which showed 
100% sensitivity to Vancomycin, 80%to Amikacin, 60% to Erythromycin, 
50% to ciprofloxacin. 
70% of Staph aureus and66% of Staph epidermidis were found to be 
Methicillin resistant. This indicates MRSA and MRS epidermidis was more 
common in ICU pts. This indicates the use of inadequate antibiotics during 
empirical therapy, invasive procedures like IV catheters which breach the 
host defense mechanism and longer duration of hospitalization may 
selectively enhance the growth of drug resistant pathogens. 
Sensitivity to Vancomycin was detected by Macrobroth dilution 
method. All isolates showed MIC within sensitivity range (<2µg/ml).  
In spite of this the septicaemic patients have high mortality rate due to 
invasive procedures (ie health care interventions) leading to biofilm 
formation and length of stay in hospital and associated co-morbid 
conditions. 
Enterococcus faecalis showed 50% sensitivity to Vancomycin, 50% 
to ciprofloxacin and Amikacin. Isolate identified as Vancomycin resistant 
Enterococci (VRE) showed MIC >32µg/ml by macrobroth technique. 
 
Among gram negative organisms Pseudomonas aeruginosa was the 
most common isolate which showed 81%Imipenemsensitivity , 61% to 
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Ciprofloxacin, 55% to CFS , 55% to Amikacin, 45% to Gentamycin, 45% to 
ceftazidime. 
Among the mechanism of resistance to third generation 
cephalosporins, production of ESBL is the most common mechanism 
observed in this study.18.19% of Pseudomonas aeruginosa were found to 
MBL producers. (Table 10). However no isolate was found to be AmpC 
producers.  
Out of 11 isolates of Pseudomonas aeruginosa screened for ESBL and 
MBL production 6 (54.5 %) were found to be ESBL positive and 2 (18.2%) 
were found to be MBL positive respectively by screening method and 
confirmatory tests (Table 13 ). 
Similarly ESBL producers were found most commonly in 
Klebsiellapneumoniae (70%), E.coli (60%), Pseudomonas aeruginosa (54%) 
and Acinetobacterspp (50%). 
The common source of blood stream infection in IMCU patients 
include the lungs, skin, subcutaneous tissue and intravascular catheters. In 
this study, the most common source of BSI was IV catheters (25.4%), 
followed bygenitourinary sources (22.2%). This shows that common source 
ofBSI was Intravascular catheters(mainly central venous catheter in thus 
study) which is an important predisposing factor for Bacteremia.This 
 83 
 
correlated with the study of prowle et al 2004. No intravenous drug abusers 
were found in this study. 
Candida albicans was reported in 2 (3.17%) of cases and Candida 
tropicalis 2 ( 3.17%) of cases in the present study. This is similar to Lymn et 
al55 who reported, C.albicans & C.tropicalis (24%) of equal incidence 
forBSI in ICU patients.Grace et al , Prasad et al ,Baradkar et al, pfeller 
et al reported C. albicans  (60%) to be the most common isolate from BSI in 
critical care units followed by Candida  tropicalis ( 30%). Capoor et al 54 
reported Candida tropicalis as the causative agent for 38.7% of candidemia. 
Both Candida albicans and Candida tropicalis showed 100% 
sensitivity to Amphotericin B. Fluconazole resistance was observed in 
C.tropicalis isolate. A study conducted by Law D et al reported that 
C.tropicalis (20 %) were resistant to  Fluconazole. 
There was a total of 22 death in BSI positive cases in this present 
study. The overall mortality rate is 35%. Prowle et al 2009 reported over all 
mortality rate in ICU about 40%. Out of 22 deaths, 31.8% were due to 
Pseudomonas aeruginosa. Out of 4 candidal spp.3 deaths occurred in IMCU 
patients.This shows high mortality rate for Fungemia in critical care set up. 
Among deaths due to Bacteria, Pseudomonas spp had high mortality rate 
due to invasive procedures, long hospital stay& Biofilm formation in IMCU 
patients. 
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SUMMARY & CONCLUSION 
 
A prospective study was undertaken over a period of one year in 150 
patients. To determine the bacterial and fungal isolates causing septicaemia 
in patients admitted to IMCU (Intensive Medical Care Unit). 
Fever (10%) and Respiratory distress (19.45%) were the most 
common presenting symptoms. 
The culture positivity is 42%. The Spectrum of bacterial isolates were 
38.09% GPC (Gram Positive cocci), 55.55% GNB (Gram Negative Bacilli). 
Fungi contributed to remaining 6.34% 
The common Organisms isolated were CONS (Coagulase negative 
staphylococci) 19.04% and Pseudomonas aeruginosa 17.46%. 
The Epidemology of BSI in IMCU in the study was nosocomial 
acquired contributing to 55.6% of cases. 
All GPC showed 100% sensitivity for Vancomycin except 
Enterococcus faecilis, 80% sensitivity to Amikacin, 77% sensitivity to 
Ciprofloxacin and 60% sensitivity to Erythromycin. 
All GNB except Pseudomonas aeruginosa showed 100% for 
Imipenam, 90% sensitivity to gentamycin 80% sensitivity to Amikacin, 70% 
sensitivity to Ciprofloxacin and 60% sensitivity to Erythromycin. 
Among the Staphylococcus aureus  70% were methicillin resistant 
and 30% were   methicillin sensitive.  Staphylococcus epidermidis 66% 
were methicillin resistant  and Staphylococcus schleiferi subsp.schleiferi  
66.7% .were methicillin resistant. 
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70% of Klebsiella pneumoniae & 60% of E.coli were ESBL 
producers. 
Candida was found in 6.34% of Septicaemic cases.  The commonest 
being C.albicans  (3.16%) & C.tropicalis (3.16%). 
All Candida isolates were sensitive to Amphotericin B.  
In this study IV Catheters are main predisposing factor for BSI in 
IMCU contributing to 31.7% of cases.  
The most common source of infections are invasive procedures  like 
Central Venus Catheterization (CVC) in critical care setting followed by 
genitourinary sources in Hospital acquired blood stream infections. 
Presence of  Methicilin resistant Staphylococcus aureus(MRSA) and 
Extended spectrum β lactamase (ESBL) producing gram negative bacilli in 
IMCU setting leading to grave prognosis. So irrational use of antibiotics 
leads to emergence of resistant organisms. 
To reduce the morbidity and mortality in IMCU setting following 
interventions are followed. 
1. Adherence to guidelines on insertion and care of Central Venous 
Catheterization. 
2. Use of antimicrobial or antiseptic impregnated Catheters 
3. Improved hand hygiene.  
 
 
  
 
PROFORMA 
       IP No: 
 Name : 
 Age : 
 Sex : 
 Occupation : 
 Address : 
 Presenting complaints : 
 Risk factors / demographic profile of the parties 
Underlying illness 
Diabetes mellitus 
Chronic Lung disease 
Chronic Heart failure 
Chronic Renal failure 
Chornic Liver disease 
Uremia 
Neoplasm 
Trauma 
Coma 
Pronged stay in hospital 
Prolonged stay in ICU 
Broad spectrum antibiotic & its duration 
Immunosuppressive therapy 
Chemotherapy 
HIV/AIDS 
Arteriovenous graft 
Splenectomy 
 
  
 
Procedures 
Intra venous Catherization 
Reason & duration of catheterization 
Any other invasive procedure 
Prior Surgery 
Hospital care personnels 
 Physical examination 
 Laboratory evaluation 
Biochemical 
Blood sugar 
HP Alc 
Urea 
Creatinine 
Neutropernia 
Other investigation 
WBC count 
ESR 
USG 
Microbiological investigation: 
• Gram’s Stain: 
• Culture : 
BHI Broth 
Fungal culture on SDA 
Antimicrobial susceptibility pattern 
AntiBacterial susceptibility by Disc diffusion 
Antifungal susceptibility by Microboth dilution technique. 
  
  
 
 
  
 
APPENDIX 
STAINING 
I) Gram staining 
     Methyl violet (2%)- 10g methyl violet in 100 ml absolute 
alcohol in 1 litre of distilled water 
Grams iodine – 10 g Iodine in 20g KI (fixative) 
Acetone- Decolourising agent 
Carbol fuchsin 1%- secondary stain 
2) CULTURE MEDIA 
Brain Heart Infusion Biphasic medium 
          Sodium citrate 1gm 
         Sodium chloride 4 gm 
         Sodium phosphate 5 gm 
         Dextrose 10 gm 
          Peptone 10 gm 
Brain heart Infusion Broth 
        Brain  infusion broth 250 ml 
        Heart infusion broth 750 ml 
        Sodium polyanethol sulponate 0.25gm 
     Obtain Ox brain and heart. Remove all  fat from the heart.cut 
into small pieces and grind . add distilled water three times and 
  
 
keep at 40 C overnight. From the brain , remove meninges fully 
and then , weigh. Add distilled water and mash by using hand keep 
in the cooler over night. Next morning boil the brain and heart 
separately for 30 minutes. Then filtered through cotton layer. 
Measure each broth separately. Mix both infusions and the 
remaining ingredients. dissolve well and adjust ph of the entire 
amount to 7.4 to 7.6 Autoclave   at 121 c for 15 minutes. 
Brain heart infusion agar slant 
          Same as above , in addition it contain agar. Autoclave at  
1210 c for 15 minutes. Distribute in screw capped bottles and slant 
is allowed to solidify, then broth is distributed in bottles. 
Trypticase soy broth  
 Pancreatic digest or casein 17.0 gram 
 Enzymatic soy Digest 3.0 gram 
Sodium chloride 5.0 gram 
Dipotassium phosphate 2.5 gram 
Dextrose         2.5 gram 
Sodium polyanethol sulfonate  0.3 gram  
 Final ph adjusted to 7.3 ±0.2 . autoclave at 1210  C for 15 minutes 
and distribute in screw capped bottles .  
  
  
 
Blood Agar (5% sheep blood agar) 
      Peptone    - 10g 
       Nacl     -  5g    
       Distilled water  -1 Ltr 
       Agar    - 10g 
    Dissolve ingredients in distilled water by boiling , and add 5% 
sheep blood (sterile) at 550 C adjust ph to7.4    . 
 Cornmeal agar  
          Cornmeal                         -40g 
           Agar                               -15g 
           Water                               -1 liter 
 Boil the corn meal in 1 liter of water for 60 min . filter through 
muslin and add the agar . Steam to dissolve, dispense in required 
amounts and autoclave at 1150 C for 30 min. allow to cool to 500 C 
and pour approximately 20 ml amount into petri dishes. 
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ABBREVIATIONS 
BSI – BLOOD STREAM INFECTIONS 
CD – CLUSTER DIFFERENTIATION 
ESBL- EXTENDED SPECTRUM BETA LACTAMASE 
MRSA-METHICILLIN RESISTAN STAPHYLOCOCCUS AUREUS 
CONS-COAGULASE NEGATIVE STAPHYLOCOCCUS AUREUS 
GPC-GRAM POSITIVE COCCI 
GNB-GRAM NEGATIVE BACILLI 
  
 
s.n
o NAME 
     
AGE 
SE
X 
FEV
ER 
HR>90/
MIN 
RR>20/
MIN 
 
ASCIT
ES 
ANAE
MIA 
ICTER
US  
LYMPHADEN
OPATH 
NEUROLOGICAL 
SYMPTOMS 
URINARY 
SYMPTOMS 
SKIN 
LESION 
TUBERCULAR 
INFECTION 
CV
C 
MECHANICAL 
VENTILATOR 
URINARY 
CATHETER 
CHEMOTHE
RAPY  
HAEMODIA
LYSIS 
POSTSUR
GICAL 
RESP 
SYSTM 
1 
VENKATACH
ALAM 23 M Y       Y     Y       Y Y Y         
2 KASI 70 M Y         Y     Y     Y             
3 SIVASUNDAR 38 M Y       Y               Y Y         
4 SINDHU 13 F Y Y     Y   Y                   Y   
5 ARUNAGIRI 57 M Y   Y           Y Y   Y Y         Y 
                                            
6 RAJAMMA  55 F Y Y Y     Y Y       Y     Y       Y 
7 murugan 32 M Y       Y                   Y       
8 MANNAN 16 M Y Y                           Y     
9 
KARTHIKRAJ
A 17 M Y Y       Y Y                 Y Y   
10 ROJA 16 F Y       Y           Y               
11 KALIDOSS 36 M y       Y                 Y         
12 
PURUSHOTH
AMAN 50 M Y       Y                           
13 
SETHURAMA
N 66 M Y Y Y   Y   Y   Y Y Y               
                                            
14 SIVA 20 M Y         Y Y         Y         Y   
15 MUNUSAMY 65 M Y Y Y       Y     Y       Y       Y 
16 BABU 23 M Y Y     Y   Y                     Y 
                                            
17 IBRAHIM 40 M Y Y     Y       Y       Y   Y Y     
18 MANOHARAN 23 M Y                                   
19 
MANIKANDA
N 25 M Y Y       Y                         
20 DILLIBABU 28 M Y       Y                 Y         
21 CHINNAIAH 22 M Y Y           Y         Y           
22 RAJA 23 M Y       Y       Y       Y           
23 
BALACHAND
AR 16 M Y Y       Y Y                       
24 MURUGAN 40 M Y Y                   Y             
                                            
25 
JAGADEESW
ARI 34 F Y     Y                 Y Y         
26 SIVA 20 M Y Y       Y Y Y                     
27 MARI 48 M Y Y Y   Y   Y     Y Y             Y 
28 
DHANASEKA
R 55 M Y Y   Y             Y Y Y   Y       
29 
ASHIYA 
BEGUM 13 F Y       Y   Y Y Y                   
30 MURUGAN 22 M Y Y       Y           Y             
31 KARTHICK 17 M Y Y Y Y                           Y 
32 ANANDRAO 27 M Y Y         Y Y Y       Y           
33 SAROJA 50 F Y Y   Y         Y                   
34 SEKAR 36 M Y   Y   Y                         Y 
35 PRAVEEN 13 M Y Y       Y Y             Y         
36 SIVA 42 M Y Y     Y         Y Y   Y           
                                            
37 
CHAKKARAV
ARTHI 40 M Y Y Y   Y   Y                     Y 
38 
SENGOLMAN
I 30 M Y Y   Y                 Y   Y       
39 
LOGANATHA
N 22 M Y         Y                     Y   
40 ELUMALAI 28 M Y Y     Y     Y       Y             
41 MOHAN 34 M Y       Y               Y           
42 RAVI 42 M Y Y     Y                           
43 KUPPAN 55 M Y       Y     Y   Y Y     Y         
  
 
                                            
44 MARKANDAN 38 M Y           Y         Y Y           
45 RAMAN 65 M Y Y   Y       Y                     
46 SUMATHY 27 F Y Y Y                     Y     Y Y 
47 HAJIRA 28 F Y     Y                 Y Y         
48 SHAKIR 15 M Y Y     Y       Y                   
49 
MANIVANNA
N 21 M Y Y Y                     Y       Y 
50 MANIVEL 58 M Y Y                   Y     Y       
51 mari 32 M Y       Y                           
52 
RAJESHKAN
NA 30 M Y Y   Y               Y             
53 RAVI 47 M Y Y     Y         Y Y               
54 
PANDURANG
AN 38 M Y Y           Y Y     Y             
55 GIRI 36 M Y       Y                           
56 RAMAN 45 M Y Y   Y         Y Y                 
57 RANJITH 18 M Y Y                                 
58 
KARUNAKAR
AN 27 M Y Y     Y                           
59 ARMANALLA 50 M Y       Y                           
60 
MAASILAMA
NI 40 M Y Y                                 
61 
MANIKANDA
N 17 M Y Y Y             Y Y             Y 
62 ARMANALLA 50 M Y Y     Y                       Y   
63 ANDIASAMY 67 M Y Y     Y         Y Y               
                                            
64 MURUGAN 41 M Y Y Y                   Y         Y 
65 SHEELA 23 F Y                                   
66 SHAKIR 38 M Y                                   
67 KUSHRAJ 33 M Y                       Y           
68 
VENKATESA
N 36 M Y         Y                         
69 KANNAN 47 M Y                                   
70 
SARATHKUM
AR 18 M Y Y     Y     Y Y                   
71 
GOVINDASA
MY 54 M Y   Y     Y                 Y     Y 
72 VENDA 25 F Y Y     Y                 Y         
73 BHARGAR 25 M Y     Y                             
74 
KRISHNAVEN
I 52 F Y Y     Y           Y               
75 AKASHRAJ 12 M Y                                   
76 SAUKATH ALI 38 M Y Y Y                     Y       Y 
77 
UMACHANDR
AN 39 M Y       Y                 Y         
78 
KARTHIKEYA
N 39 M Y Y     Y                           
79 GUNASEKAR 45 M Y                               Y   
80 DEVI 32 F Y Y                                 
81 SUNITHA 31 F Y Y     Y     Y Y           Y       
82 KOTHANDAN 50 M Y Y     Y             Y             
                                            
83 PREMKUMAR 13 M Y Y           Y                     
84 
VENKATESA
N 40 M Y Y Y     Y                       Y 
85 
GUNASEKAR
AN 45 M Y       Y             Y             
86 SAVITHA 55 F Y Y     Y   Y                       
87 RAJA 55 M Y Y Y   Y                         Y 
88 MANI 50 M Y     Y               Y             
89 SUDHA 31 F Y                                   
90 MURUGAN 38 M Y                                   
  
 
91 JEBA 45 F Y       Y           Y               
92 GOPI 35 M Y Y     Y       Y                   
93 RAJA 28 M Y Y   Y                             
94 SURYA 29 F Y Y     Y         Y Y               
95 RAMESH 46 M Y     Y                             
96 PREMKUMAR 24 M Y Y   Y         Y                   
97 SAVITHA 18 F Y Y                       Y         
98 SURESH 38 M Y Y     Y             Y             
99 SENTHIL 35 M Y Y       Y           Y Y           
10
0 BABU 29 M Y         Y         Y Y             
10
1 RAJU 18 M Y Y   Y                             
10
2 RAMU 19 M Y       Y                           
10
3 RAMESH 31 M Y Y     Y                       Y   
10
4 SAROJA 15 F Y Y                                 
10
5 LEELA 23 F Y       Y   Y                       
10
6 ASHOK 29 M Y       Y                           
10
7 PALANI 32 M Y Y       Y           Y   Y         
10
8 RAMAIAH 26 M Y Y     Y                           
10
9 VALLI 40 F Y Y               Y Y               
11
0 MUNUSAMY 52 M Y Y               Y Y     Y         
11
1 MURUGAN 38 M Y       Y                           
11
2 NARAYANAN 55 M Y Y     Y         Y Y               
11
3 MANI 44 M Y       Y             Y Y           
11
4 RANJITH 48 M Y Y     Y       Y Y Y               
11
5 SANGITA 24 F Y Y                       Y         
11
6 SUKUMAR 41 M Y                                   
11
7 BABU 45 M Y       Y   Y         Y             
11
8 GIRI 36 M Y       Y                           
11
9 KRISHNAN 24 M Y Y                                 
12
0 PRABHU 37 M Y       Y                           
12
1 BANU 33 F Y                   Y Y             
12
2 BALA 50 M Y                       Y           
12
3 SATHISH 43 M Y                                   
12
4 INDRAN 42 M Y                     Y   Y       Y 
12
5 RAJINI 48 M Y Y                                 
12
6 SARALA 24 F Y Y     Y                           
12
7 SASIKUMAR 36 M Y                     Y             
12
8 KUMAR 43 M Y       Y                           
12
9 MARI 36 M Y       Y           Y     Y         
13
0 RAVI 26 M Y Y                     Y     Y     
13
1 PRAKASH 37 M Y       Y             Y             
13
2 MALA 30 F Y     Y             Y     Y         
13
3 KATHIR 45 M Y   Y                               
  
 
13
4 SUGUNA 40 M Y                   Y Y       Y     
13
5 RAMU 48 M Y Y                                 
13
6 PARVATHI 24 F Y Y     Y           Y     Y         
13
7 VIGNESH 44 M Y                         Y         
13
8 BALAKUMAR 45 M Y       Y           Y Y             
13
9 MANI 36 M Y       Y                           
14
0 KUMAR 24 M Y Y                                 
14
1 BALA 37 M Y                     Y           Y 
14
2 TAMILSELVI 32 F Y                         Y         
14
3 VARUN 32 M Y                       Y           
14
4 
RAMACHAND
AR 48 M Y Y     Y                           
14
5 ROHINI 42 F Y Y     Y             Y             
14
6 MARAN 34 M Y                                   
14
7 STALIN 45 M Y       Y           Y   Y           
14
8 KUMAR 36 M Y       Y             Y   Y         
14
9 KAMAL 33 M Y Y                                 
15
0 KARTHIK 37 M Y   Y                               
 
